CN102940721A - Medicine for treating chronic pelvic inflammation - Google Patents
Medicine for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN102940721A CN102940721A CN2012104942559A CN201210494255A CN102940721A CN 102940721 A CN102940721 A CN 102940721A CN 2012104942559 A CN2012104942559 A CN 2012104942559A CN 201210494255 A CN201210494255 A CN 201210494255A CN 102940721 A CN102940721 A CN 102940721A
- Authority
- CN
- China
- Prior art keywords
- parts
- chronic pelvic
- pelvic inflammation
- medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 17
- 230000001684 chronic effect Effects 0.000 title claims abstract description 13
- 229940079593 drug Drugs 0.000 title claims abstract description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 241000555682 Forsythia x intermedia Species 0.000 claims abstract 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 9
- 241000241550 Cyathula Species 0.000 claims description 4
- 241000501098 Sargentodoxa Species 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 19
- 208000002193 Pain Diseases 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 241000411851 herbal medicine Species 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003101 oviduct Anatomy 0.000 description 4
- 241000555712 Forsythia Species 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 206010000084 Abdominal pain lower Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 2
- 241000762515 Hydrosalpinx Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 208000007893 Salpingitis Diseases 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 208000030843 hydrosalpinx Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 241000219317 Amaranthaceae Species 0.000 description 1
- 208000007415 Anhedonia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 235000008738 Clausena lansium Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 244000011358 Patrinia scabiosaefolia Species 0.000 description 1
- 235000009267 Patrinia scabiosaefolia Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 241000510764 Villosa Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
The invention relates to a Chinese herbal medicine for treating chronic pelvic inflammation. Pelvic inflammation is an infectious disease easily attacks young women, is easily transformed into the chronic pelvic inflammation, and brings great pain to patients. By means of long-term study and clinical verification, an oral Chinese medicine with better treatment effects is invented. Consumption of components (the optimum ratio of the components) of the Chinese herbal medicine is determined after much exploration. The Chinese herbal medicine comprises 30 parts of Sargent gloryvine, 30 parts of patrinia, 15 parts of common peony root, 15 parts of root bark of peony tree, 20 parts of red sage, 30 parts of dandelion, 20 parts of forsythia, 10 parts of golden cypress, 20 parts of radix cyathulae, 10 parts of cordate houttuynia and 10 parts of corydalis tuber. The Chinese medicine composition is used for more effectively treating the chronic pelvic inflammation, all medicines achieve synergistic effects, and the Chinese medicine composition has the functions of clearing heat, removing toxicity, promoting blood circulation, removing blood stasis, eliminating illness, removing stagnation, promoting qi circulation, relieving pain and the like, so that the chronic pelvic inflammation can be effectively treated.
Description
Technical field
The present invention relates to a kind of Chinese herbal medicine, especially a kind of Chinese herbal medicine for the treatment of chronic pelvic inflammatory disease.
Background technology
Chronic pelvic inflammatory disease is the infectious disease that is mainly in young woman, and common sympton is that lower abdominal pain, heating, vaginal secretions increase.Stomachache is persistence, activity or sexual intercourse postemphasis.Gynecologial examination can have lifting pain or uterus tenderness or attachment area tenderness, and body temperature surpasses 38 sometimes, and erythrocyte sedimentation rate or c reactive protein raise, and transvaginal sonography shows that fallopian tube increases slightly, hydrosalpinx, accompanies or do not accompany pelvic hydrops.Fallopian tube ovary lump.Treatment is take antibiotic medicine as main at present, and the course for the treatment of is considerable, and easily drug resistance changes into chronic pelvic inflammatory disease; Operative treatment both brings very large misery to the patient in case of necessity.
Summary of the invention
The inventor is through studying for a long period of time, and the repeatedly checking by clinical trial, finally found the extract oral medicine that is used for the treatment of chronic pelvic inflammatory disease that better curative effect is arranged, and this medicine has heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, the effects such as Disorder eliminating stagnation, promoting the circulation of QI to relieve pain disappear.
Technical assignment of the present invention provides a kind of Chinese medicine composition of more efficiently treatment pelvic inflammatory disease.30 parts of medicament selection Caulis Sargentodoxaes of the present invention, 30 parts of Herba Patriniae, 15 parts of Radix Paeoniae Rubra, 15 parts of Cortex Moutans, 20 parts of Radix Salviae Miltiorrhizaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 10 parts of Cortex Phellodendris, 20 parts of Radix Cyathulaes, 10 parts of Herba Houttuyniae, 10 parts of Rhizoma Corydalis make up, with these drug regimens so that each efficacy of drugs produces synergism, thereby can effectively treat pelvic inflammatory disease.Wherein: Caulis Sargentodoxae: be the rattan of Sargentodoxaceae bejuco Caulis Sargentodoxae.The property bitter, hot, be slightly cold.Return large intestine, Liver Channel.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.
Herba Patriniae: be the herb of Valerianaceae herbaceous plant Patrinia scabiosaefolia Fisch or patrima villosa.The property bitter, hot, be slightly cold.Return large intestine, liver, stomach warp.Has heat-clearing and toxic substances removing, the effect of promoting blood circulation and stopping pain.
Radix Paeoniae Rubra: be the root of Ranunculaceae herbaceous plant Radix Paeoniae or river Radix Paeoniae Rubra.The property bitter, hot, be slightly cold.Return liver, heart channel.Has clearing away heat and cooling blood, the effect of blood circulation promoting and blood stasis dispelling.
Cortex Moutan: be the root bark of Ranunculaceae undershrub plant Paeonia suffruticosa.The property bitter, hot, be slightly cold.Return kidney, liver, heart channel.Has clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, the effect of reducing the asthenic fever.
Radix Salviae Miltiorrhizae: be the root of Labiatae herbaceos perennial Radix Salviae Miltiorrhizae.The property hot, bitter, be slightly cold.GUIXIN, Liver Channel.Has blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle, the effect that relieving restlessness is calmed the nerves.
Herba Taraxaci: be the herb of catananche's Herba Taraxaci.The property bitter, sweet, cold.Return liver, stomach, lung meridian.Has heat-clearing and toxic substances removing, liver heat removing stomach lung-heat, the effect of eliminating damp-heat.
Fructus Forsythiae: be the fruit of Oleaceae shrub plant Fructus Forsythiae.The property bitter, little suffering, cold.Return lung, stomach, the heart, small intestine meridian.Has heat-clearing and toxic substances removing, dispelling wind heat, the effect of the heat that clears away heart-fire.
Cortex Phellodendri: the bark of removing cork for Rutaceae magaphanerophytes wampee.The property bitter, cold.Return liver, gallbladder, large intestine, stomach, kidney, urinary bladder channel.Heat clearing and damp drying, eliminating fire and detoxication, reducing the asthenic fever.
Radix Cyathulae: be the root of Amaranthaceae herbaceos perennial Radix Achyranthis Bidentatae and Radix Cyathulae.The property hot, bitter, sweet, flat.Return liver, kidney channel.Has blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, conducting blood to flow downwards, the effect of inducing diuresis for treating stranguria syndrome.
Herba Houttuyniae: be the herb of Saururaceae herbaceous plant Herba Houttuyniae.The property hot, cold.Return lung, stomach, liver, urinary bladder channel.Has heat-clearing and toxic substances removing, eliminating heat from the lung, the effect of eliminating damp-heat.
Rhizoma Corydalis: be the tuber of Papaveraceae herbaceos perennial Rhizoma Corydalis.The property hot, bitter, temperature.Return liver, the heart, spleen channel.Have and invigorate blood circulation, circulation of qi promoting, pain relieving effect.
Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain.Radix Cyathulae is ignited, blood is descending.Cortex Moutan, Fructus Forsythiae, the evacuation of pus of drawing out pus by applying a plaster to the affected part, promoting blood circulation and detumescence.Herba Patriniae, Herba Taraxaci, Herba Houttuyniae: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation
The consumption of drug component of the present invention is also groped to draw through the inventor in a large number, each amounts of components is for to have preferably curative effect in the following weight proportioning: Caulis Sargentodoxae 15-30 part, Herba Patriniae 15-30 part, Radix Paeoniae Rubra 10-15 part, Cortex Moutan 6-15 part, Radix Salviae Miltiorrhizae 12-20 part, Herba Taraxaci 10-30 part, Fructus Forsythiae 15-20 part, Cortex Phellodendri 6-10 part, Radix Cyathulae 12-20 part, Herba Houttuyniae 10-30 part, Rhizoma Corydalis 3-12 part
Its best proportioning is: 30 parts of Caulis Sargentodoxaes, 30 parts of Herba Patriniae, 15 parts of Radix Paeoniae Rubra, 15 parts of Cortex Moutans, 20 parts of Radix Salviae Miltiorrhizaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 10 parts of Cortex Phellodendris, 20 parts of Radix Cyathulaes, 10 parts of Herba Houttuyniae, 10 parts of Rhizoma Corydalis
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, such as pill, powder, tablet, oral liquid etc.For example these crude drug pulverize mix homogeneously can be made powder takes after mixing it with water; Can use decocting, get after filtration filtrate, make oral liquid; Also can directly take decoction in case of necessity.Also can densely be fried into the 100ml decoction and fill with anus usefulness.
Medicine of the present invention has the effects such as blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, eliminating stasis and resolving masses, Xiao Disorder pain relieving, and short treating period is evident in efficacy, without any side effects, according to clinical 200 routine patients are observed statistics, take medicine obvious effective rate course for the treatment of obvious effective rate 80%, two course for the treatment of 86% of the present invention.
The specific embodiment
Take by weighing following each medicine:
30 parts of Caulis Sargentodoxaes, 10 parts of 10 parts of Rhizoma Corydalis of beans grass 20 parts of Herba Houttuyniae of 10 portions of Radix Cyathulaes of 20 portions of Cortex Phellodendris of 30 parts of Fructus Forsythiaes of 20 parts of Herba Taraxacis of 15 parts of Radix Salviae Miltiorrhizaes of 15 parts of Cortex Moutans of 30 parts of Radix Paeoniae Rubra
Said medicine is put in the mortar successively and is ground well, and crosses 100 mesh sieves, then packing two pouches; When taking one day twice, once a bag, 21 days was a course for the treatment of.
The below is the clinical data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 200 examples for medical treatment, all make a definite diagnosis through gynecologial examination, its age 22-51 year, average 32 years old.
Two, diagnostic criteria
1 hypogastric region rest pain; 2 menoxenia, sexual anhedonia, leucorrhoea grow in quantity; 3 gynecologial examinations: lifting pain, poor, the tenderness of palace body mobility, the one or both sides attachment area thickens, tenderness, or enclosed mass is arranged.4 special standards: ultrasonic prompting fallopian tube increases slightly, hydrosalpinx, companion or do not accompany pelvic hydrops, fallopian tube ovary lump, and laparoscopic examinations showed organic pelvic inflammatory diseases sign; 5 additional standards: body temperature surpasses 38 ℃, and erythrocyte sedimentation rate or c reactive protein raise.
Three, Therapeutic Method
The patient takes medicine of the present invention, and one day twice, once a bag.
Four, efficacy assessment standard
Produce effects: after finishing the course for the treatment of, the clinical symptoms complete obiteration.
Take a turn for the better: symptom is alleviated substantially.
Invalid: remission is not obvious.
Five, therapeutic outcome
| Treatment time | Produce effects (example) | Obvious effective rate % | Take a turn for the better (example) | Improvement rate % | Invalid (example) | Inefficiency % |
| One course for the treatment of | 160 | 80 | 32 | 16 | 8 | 4 |
| Two courses for the treatment of | 172 | 86 | 10 | 20 | 8 | 4 |
Model case:
One, Mrs Yang, 28 years old, the From Shandong Rizhao people, more than the swollen pain of patient's lower abdomen pendant half a year, the time heavy when light, tenderness, soreness of the waist and knees, the leucorrhea amount is many at ordinary times, and is dizzy weak, dim complexion, patient tells through measuring many, and stomachache is arranged when menstrual period and sexual intercourse.The 2 years always unpregnancies of marrying.Gynecologial examination: lifting pain, vaginal secretions is many, the uterus tenderness, the left side attachment district thickens tenderness.Be diagnosed as chronic pelvic inflammatory disease.
Take medicine of the present invention after course for the treatment of, the patient feels symptom and obviously alleviates, the swollen pain of lower abdomen pendant disappears, continue to take medicine of the present invention after course for the treatment of, gynecologial examination lifting pain, uterus tenderness, left side attachment district thicken tenderness and all obviously alleviate, menses are normal, continue a course for the treatment of, and are conceived after four months.
Two, Mrs Wang, 24 years old, people from Linyi, Shandong, 20 days post-abortions, lower abdominal pain 2 days.It is uncomfortable that lower abdomen pendant is swollen, 38.2 ℃ of body temperature, and the cervix uteri purulent secretion, lifting pain, palace body tenderness is obvious, and the bilateral attachment area is without unusually.Endometrial biopsy histologic study proved endometritis.Be diagnosed as chronic pelvic inflammatory disease.
Take medicine of the present invention after course for the treatment of, lower abdomen is uncomfortable to disappear, and body temperature is normal, and the gynecologial examination sign is clearly better, and continues to consolidate a course for the treatment of curative effect.
Claims (2)
1. medicine for the treatment of chronic pelvic inflammatory disease, it is characterized in that it is made by the crude drug of following weight proportion: Caulis Sargentodoxae 15-30 part, Herba Patriniae 15-30 part, Radix Paeoniae Rubra 10-15 part, Cortex Moutan 6-15 part, Radix Salviae Miltiorrhizae 12-20 part, Herba Taraxaci 10-30 part, Fructus Forsythiae 15-20 part, Cortex Phellodendri 6-10 part, Radix Cyathulae 12-20 part, Herba Houttuyniae 10-30 part, Rhizoma Corydalis 3-12 part.
2. medicine according to claim 1 is characterized in that it is made by the crude drug of following weight proportion:
30 parts of Caulis Sargentodoxaes, 30 parts of Herba Patriniae, 15 parts of Radix Paeoniae Rubra, 15 parts of Cortex Moutans, 20 parts of Radix Salviae Miltiorrhizaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 10 parts of Cortex Phellodendris, 20 parts of Radix Cyathulaes, 10 parts of Herba Houttuyniae, 10 parts of Rhizoma Corydalis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210494255.9A CN102940721B (en) | 2012-11-28 | 2012-11-28 | Medicine for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210494255.9A CN102940721B (en) | 2012-11-28 | 2012-11-28 | Medicine for treating chronic pelvic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102940721A true CN102940721A (en) | 2013-02-27 |
| CN102940721B CN102940721B (en) | 2014-04-16 |
Family
ID=47723781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210494255.9A Expired - Fee Related CN102940721B (en) | 2012-11-28 | 2012-11-28 | Medicine for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940721B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103655795A (en) * | 2013-11-20 | 2014-03-26 | 界首市中医院 | Traditional Chinese medicine composition for treating pelvic inflammation |
| CN104644907A (en) * | 2015-01-23 | 2015-05-27 | 青岛市中心医院 | Traditional Chinese medicine formula for treating chronic pelvic inflammatory disease |
| CN104873622A (en) * | 2015-06-09 | 2015-09-02 | 苏州卫生职业技术学院 | Traditional Chinese medicine composition for treating pelvic inflammation and preparation method thereof |
| CN105233161A (en) * | 2015-10-30 | 2016-01-13 | 李婷 | Medicine for treating pelvic inflammation |
| CN105521438A (en) * | 2016-01-13 | 2016-04-27 | 岳晓燕 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
| CN106177204A (en) * | 2016-08-03 | 2016-12-07 | 韦爱小 | A kind of Chinese medicine composition treating acute pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
| CN112675241A (en) * | 2021-01-06 | 2021-04-20 | 柳州市妇幼保健院 | Externally applied medicine for treating pelvic inflammation and preparation method thereof |
| CN113599478A (en) * | 2021-07-28 | 2021-11-05 | 佛山市妇幼保健院 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000319191A (en) * | 1999-03-05 | 2000-11-21 | Takeda Chem Ind Ltd | Cyclic gmp specific phosphodiesterase inhibitor and sexual dysfunction-improving drug |
| CN1689591A (en) * | 2004-04-23 | 2005-11-02 | 江西华太药业有限公司 | Chinese medicine for treating gynopathy and its preparing process |
| WO2008113118A1 (en) * | 2007-03-16 | 2008-09-25 | Medcina Group Pty Ltd | Compositions and methods for treating male infertility |
| WO2008119131A1 (en) * | 2007-04-02 | 2008-10-09 | Medcina Group Pty Ltd | Herbal compositions and methods for treating female infertility |
| CN102293840A (en) * | 2011-07-30 | 2011-12-28 | 胡海舰 | Traditional Chinese medicinal composition for treating chronic pelvic inflammation |
-
2012
- 2012-11-28 CN CN201210494255.9A patent/CN102940721B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000319191A (en) * | 1999-03-05 | 2000-11-21 | Takeda Chem Ind Ltd | Cyclic gmp specific phosphodiesterase inhibitor and sexual dysfunction-improving drug |
| CN1689591A (en) * | 2004-04-23 | 2005-11-02 | 江西华太药业有限公司 | Chinese medicine for treating gynopathy and its preparing process |
| WO2008113118A1 (en) * | 2007-03-16 | 2008-09-25 | Medcina Group Pty Ltd | Compositions and methods for treating male infertility |
| WO2008119131A1 (en) * | 2007-04-02 | 2008-10-09 | Medcina Group Pty Ltd | Herbal compositions and methods for treating female infertility |
| CN102293840A (en) * | 2011-07-30 | 2011-12-28 | 胡海舰 | Traditional Chinese medicinal composition for treating chronic pelvic inflammation |
Non-Patent Citations (4)
| Title |
|---|
| 李僖如: "《妇科疾病古今效方》", 31 December 1998, 科学出版社 * |
| 程爵棠编著: "《百病中医诸窍疗法》", 31 January 1994, 学苑出版社 * |
| 蔡汝勤: "综合治疗慢性盆腔炎56例", 《中医研究》 * |
| 谢辉峰等: "中西医结合治疗慢性盆腔炎120 例", 《山西中医》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103655795A (en) * | 2013-11-20 | 2014-03-26 | 界首市中医院 | Traditional Chinese medicine composition for treating pelvic inflammation |
| CN104644907A (en) * | 2015-01-23 | 2015-05-27 | 青岛市中心医院 | Traditional Chinese medicine formula for treating chronic pelvic inflammatory disease |
| CN104873622A (en) * | 2015-06-09 | 2015-09-02 | 苏州卫生职业技术学院 | Traditional Chinese medicine composition for treating pelvic inflammation and preparation method thereof |
| CN104873622B (en) * | 2015-06-09 | 2017-12-22 | 苏州卫生职业技术学院 | A kind of Chinese medicine composition for treating pelvic infecton and preparation method thereof |
| CN105233161A (en) * | 2015-10-30 | 2016-01-13 | 李婷 | Medicine for treating pelvic inflammation |
| CN105521438A (en) * | 2016-01-13 | 2016-04-27 | 岳晓燕 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
| CN106177204A (en) * | 2016-08-03 | 2016-12-07 | 韦爱小 | A kind of Chinese medicine composition treating acute pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
| CN112675241A (en) * | 2021-01-06 | 2021-04-20 | 柳州市妇幼保健院 | Externally applied medicine for treating pelvic inflammation and preparation method thereof |
| CN113599478A (en) * | 2021-07-28 | 2021-11-05 | 佛山市妇幼保健院 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102940721B (en) | 2014-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872418B (en) | Medicine for treating pelvic inflammation | |
| CN102940721B (en) | Medicine for treating chronic pelvic inflammation | |
| CN103157051B (en) | Medicament for treating vaginitis | |
| CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
| CN101869640A (en) | Traditional Chinese medicine for treating myopia | |
| CN103751562A (en) | Traditional Chinese medicine for treating calculus | |
| CN101361949B (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
| CN102357211A (en) | Traditional Chinese medicine composition for curing cancers | |
| CN101129736A (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN102895610A (en) | Medicine for treating edema | |
| CN102349980B (en) | Traditional Chinese medicine for treating rheumatism | |
| CN104887809A (en) | Medicine for treating gynecologic inflammation and preparation method thereof | |
| CN103156943B (en) | Medicament for treating infertility of obstructive uterine tube | |
| CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
| CN103920046A (en) | Medicine for treating cystitis and preparation method thereof | |
| CN103127427B (en) | Chinese medicinal composition for treating chronic pelvic inflammation | |
| CN101632831B (en) | Traditional Chinese medicine medicated wine for treating waist and leg pains | |
| CN105079549A (en) | Traditional Chinese medicine for treating lupus nephritis | |
| CN104435362B (en) | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease | |
| CN104257813B (en) | A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof | |
| CN103536863B (en) | A kind of Chinese medicine for the treatment of the infertile disease of obstruction of collaterals by blood stasis pattern of syndrome | |
| CN103055175A (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN103989885A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation | |
| CN104587256A (en) | Traditional Chinese medicine composition for treating prostatitis | |
| CN104623506A (en) | Traditional Chinese medicine for treating infertility gynaecopathia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. Free format text: FORMER OWNER: XUE HONGXI Effective date: 20150414 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276800 RIZHAO, SHANDONG PROVINCE TO: 226156 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150414 Address after: 226156 Nantong Binhai New Area, Haimen City, Hong Kong West Road, No. 999, No. Patentee after: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. Address before: 276800 No. 35, hope road, Shandong, Rizhao City Patentee before: Xue Hongxi |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181123 Address after: 255000 South District, 20 Floor, Block B, Pioneering Torch Plaza, 111 Liuquan Road, Zibo High-tech Zone, Shandong Province Patentee after: Zibo blue ribbon Health Management Co., Ltd. Address before: 226156 999 Harbour Road, Binhai New Area, Haimen, Nantong, Jiangsu Patentee before: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 Termination date: 20181128 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |